MRNA
NASDAQ · Biotechnology
Moderna Inc
$154.04
-4.03 (-2.55%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+479.97%
YTD
+399.16%
Open$158.36
Previous Close$158.07
Day High$159.79
Day Low$150.26
52W High$176.66
52W Low$22.28
Volume—
Avg Volume11.79M
Market Cap63.11B
P/E Ratio—
EPS$-7.98
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.98
Above
SMA 200
$29.64
Above
RSI (14)
57.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
30 analysts
Price Target
-3.0% upside
Current
$154.04
$154.04
Target
$149.45
$149.45
$89.97
$149.45 avg
$212.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.05B | 4.40B | 2.23B |
| Net Income | -2,972,029,013 | -5,744,901,442 | -285,156,561 |
| Profit Margin | -145.2% | -137.9% | -12.8% |
| EBITDA | -3,010,989,653 | -6,143,557,066 | -355,384,473 |
| Free Cash Flow | — | — | -237,052,091 |
| Rev Growth | -53.4% | -53.4% | +3.0% |
| Debt/Equity | 0.07 | 0.07 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.96 | -0.02% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $385.65 | +1.55% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.11 | -0.52% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $508.34 | -1.55% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $784.85 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $239.56 | -2.42% | 40.0 | 32.33B |